Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 27;23(1):537.
doi: 10.1186/s13063-022-06348-z.

Getting it wrong most of the time? Comparing trialists' choice of primary outcome with what patients and health professionals want

Affiliations

Getting it wrong most of the time? Comparing trialists' choice of primary outcome with what patients and health professionals want

Shaun Treweek et al. Trials. .

Abstract

Background: Randomised trials support improved decision-making through the data they collect. One important piece of data is the primary outcome - so called because it is what the investigators decide is the most important. Secondary outcomes provide additional information to support decision-making. We were interested in knowing how important patients and healthcare professionals consider the outcomes (especially the primary outcome) measured in a selection of published trials.

Methods: The work had three stages: (1) We identified a body of late-stage trials in two clinical areas, breast cancer management and nephrology. (2) We identified the primary and secondary outcomes for these trials. (3) We randomly ordered these outcomes and presented them to patients and healthcare professionals (with experience of the clinical area), and we asked them to rank the importance of the outcomes. They were not told which outcomes trial authors considered primary and secondary.

Results: In our sample of 44 trials with 46 primary outcomes, 29 patients, one patient representative and 12 healthcare professionals together ranked the primary outcome as the most important outcome 13/46 times or 28%. Breast cancer patients and healthcare professionals considered the primary outcome to be the most important outcome for 8/21 primary outcomes chosen by trialists. For nephrology, the equivalent figure was 5/25. The primary outcome appeared in a respondent's top 5 ranked outcomes 151/178 (85%) times for breast cancer and 225/259 (87%) times for nephrology even if the primary was not considered the most important outcome.

Conclusions: The primary outcome in a trial is the most important piece of data collected. It is used to determine how many participants are required, and it is the main piece of information used to judge whether the intervention is effective or not. In our study, patients and healthcare professionals agreed with the choice of the primary outcome made by trial teams doing late-stage trials in breast cancer management and nephrology 28% of the time.

Keywords: Clinical trials; Outcomes; Trial methodology.

PubMed Disclaimer

Conflict of interest statement

ST is an Editor-in-Chief of Trials. The other authors declare that they have no competing interests.

References

    1. Crowley E, Treweek S, Banister B, Breeman S, Chadburn M, Constable L, Cotton S, Duncan A, El Feky A, Gardner H, Goodman K, Lanz D, Mcdonald A, Ogburn E, Starr K, Stevens N, Fernie G. Using systematic data categorisation to quantify the types of data collected in clinical trials: the DataCat project. Trials. 2020;21:535. doi: 10.1186/s13063-020-04388-x. - DOI - PMC - PubMed
    1. Moher D, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869. - DOI - PMC - PubMed
    1. Heneghan C, Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials. 2017;18:122. doi: 10.1186/s13063-017-1870-2. - DOI - PMC - PubMed
    1. Rahimi K, Malhotra A, Banning AP, Jenkinson C. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ. 2010;341:c5707. doi: 10.1136/bmj.c5707. - DOI - PMC - PubMed
    1. Williamson P.R., Altman D.G., Bagley H, et al. The COMET handbook: version 1.0. Trials. 2017;Suppl 3(18):280. doi: 10.1186/s13063-017-1978-4. - DOI - PMC - PubMed